A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
<h3>Background</h3><p dir="ltr">Predictive biomarkers of immune checkpoint inhibitor (ICI) efficacy are currently lacking for non-small cell lung cancer (NSCLC). Here, we describe the results from the Anti–PD-1 Response Prediction DREAM Challenge, a crowdsourced initiativ...
محفوظ في:
مواد مشابهة
-
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
حسب: Remy Thomas (702843)
منشور في: (2021) -
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
Immune checkpoint inhibitors: recent progress and potential biomarkers
حسب: Pramod Darvin (153341)
منشور في: (2018) -
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
حسب: Maysaloun Merhi (4246147)
منشور في: (2018)